EDUCATION AND ACADEMIC TITLES

1998 MD^a

2004 PhD^a

2010 Specialist

2015 DMSc^a

CURRENT POSITIONS

2022 – Professor^a

2017 – Head of the Clinical Research Unit^b

2014 – Gastroenterologist consultant/Chief Physician^b

PREVIOUS RESEARCH APPOINTMENTS

2016 – 2021 Associate Research Professor^a,b, 1:1 research:clinical work, “Intestinal injury and regeneration in IBD”

2015 Visiting scientist, the Langer Lab and The Karp Lab, MIT, Cambridge, MA, USA, “Intestinal regeneration”

2012 – 2015 Clinician scientist^b, 1:1 research:clinical work, “Mucosal wound healing in IBD”

2000 – 2003 PhD^a, “Apoptosis in IBD”

1994 Student research fellow, Dept of Physiology^a, “Epilepsy models”

BOARD MEMBER

2017 – Various committees, The Danish Society for Gastroenterology and Hepatology

2015 – 2019 National representative, United European Gastroenterology

2014 – 2015 Research Ethics Committee of the Capital Region

2009 – 2013 The Danish Society of Medical Philosophy of Science and Ethics

SUPERVISION AND TEACHING

Ph.D. supervision, ongoing:

2021 –  Emilie Dahl: Open label randomized controlled clinical trial of anti-integrins versus conventional treatment for checkpoint inhibitor induced colitis, Primary supervisor

2021 – Mohamed Attauabi: The influence of genetics, immunity and the microbiome on the prognosis of inflammatory bowel disease – the IBD Prognosis Study. Primary supervisor                                               

2021 – Anja Poulsen: Fibrosis generation and intestinal damage markers of Crohn’s disease. Primary supervisor

2019 – Johan Ilvemark: Predictors of treatment resistance in ASUC. Primary supervisor

Ph.D. supervision, previous:

2019 – 2022 Michelle Vernstrøm Prosberg: Trichuris suis treatment of mild to moderate UC – a RCT. Co-supervisor

2019 – 2022 Mirabella Zhao: Predictors of treatment response and disease course in patients with inflammatory bowel disease treated with biological therapy – The Danish IBD-biobank (DIB) Co-supervisor

2017 – 2020 Fredrik Bergenheim: Role of intestinal epithelial cells for tissue regeneration in IBD. Primary co-supervisor

2012 – 2015 Kristoffer Søndergaard: Role of factor XIII-A for monocyte activation in IBD. Primary co-supervisor

2012 – 2015 Mohammad Salem: Bacterial responses of monocytes and IBD. Primary co-supervisor

Master-degree supervision, ongoing:

2022 – Mariana Bronze: ILCs in IBD. Primary supervisor

Master-degree supervision, previous: 5 (medicine), 2 (molecular biology)

Teaching: Pre-graduate^a: Gastroenterology. Post-graduate^a: IBD, mucosal immunology, clinical research methods (PhD courses). Responsible for the exam of internal medicine and surgery^a

EXPERT AND PEER REVIEW, EVALUATION OF DOCTORAL DEGREES

Broad Medical Foundation, CA, USA; l’Agence Nationale de la Recherche, France; the National Czech Science Foundation; The Irish Research Council; Swiss National Science Foundation; Israeli Ministry of Innovation, Science and Technology Foundation; First opponent, PhD thesis evaluation committee, University of Tromsø; Head of PhD thesis evaluation committee^a; Head of professor assessment committee^a

PUBLICATIONS

100 (PubMed), 3 book chapters, +50 oral/posters. Papers in top journals of the field: IF>60: Nat Rev Gastr Hepat; IF>30: Gastr, IF>10: Am J Gastr, Autophagy, Biomaterials, Clin Gastr Hepat, EMBO Mol Med, Int Care Med, Nature Com, Trends in Mol Med.

BIBLIOMETRICS

H-index: 26 (Clarivate Analytics), 31 (Google Scholar)

GRANTS

Current running external funding in 13.672 kDKK allocated to JS research group.

LEADERSHIP EXPERIENCE

2017 – Head of the Clinical Research Unit^b

2014 – 2017 Head of the outpatient clinic^b

2012 – 2014 Head of research, Dept Internal Medicine, Bispebjerg Hospital

CLINICAL RESEARCH

NC+PI of 8 RCTs. PI of 3 RCTs. Sub-I of 5 RCTs. Sponsor-investigator on 1 RCT

---

^aAt UCPH

^bAt Dept. Gastroenterology, Herlev Hospital